COUNTDOWN TO START ACTIVITY
COURSE OVERVIEW
This internet live activity aims to describe the spectrum of signs and symptoms suspicious for heart failure illustrating the clinical stages of heart failure and the triggers for clinical deterioration, also, will discuss the most updated guidelines of diagnosis and management of HF, designing both a non-pharmacologic and a pharmacologic treatment plan based on a patient’s HF stage, in order to enhance patient care.
Goal Statement
The aim of this session is to discuss the most updated guidelines of diagnosis and management of HF
LEARNING OBJECTIVES
Upon the completion of this activity, the participant should be able to;
- Describe the spectrum of signs and symptoms suspicious for heart failure illustrating the clinical stages of heart failure and the triggers for clinical deterioration.
- Discuss the most updated guidelines of diagnosis and management of HF
- Design both a non-pharmacologic and a pharmacologic treatment plan based on a patient’s HF stage
- Explore the current indications, limitations and possible future applications of imaging modalities to improve the management of HF patients
- Outline the Potential benefits of SGLT-2 inhibitors in diabetic patients with established HF.
- Illustrate why T2D Patients are at greater risk of developing HF and being hospitalized due to HF.
- Proper Management of HF in DM patients.
- Discuss and analyze the results of DAPA-HF trial to assess and evaluate the efficacy of Dapagliflozin in Patients with Chronic HFrEF with or Without T2D focusing on Results in Non-diabetic Patients.
- Assess the safety and tolerability profile of Dapagliflozin in HFrEF patients even in elderly patients.
- Summarize the substantial benefits from adding Dapagliflozin to guideline-directed medical therapy (GDMT) for patients with heart failure (HF) with reduced ejection fraction (HFrEF).
- Explain how to develop preventive programs to combat HF.
TARGET AUDIENCE
This activity is intended for Cardiologists
CREDITS AVAILABLE
This activity is accredited by...
By successful completion of this CPD Internet Live activity, which includes passing post-test, you will be eligible for 1 CPD (Online) Credit.
By successful completion of this CPD Internet Live activity, which includes passing post-test, you will be eligible for 1 CPD (Online) Credit.
INSTRUCTIONS FOR PARTICIPATION AND CREDIT
To successfully earn 1 CPD credit:
- You must attend full activity.
- You must receive a minimum score of 80% on the post-test at the end slide of this activity.
- Please note that all participants should claim only the credit commensurate with the extent of their participation in the activity.
- The credit that you receive will be based on your correct user profile.
- It is our responsibility to submit participant completion information to (SCFHS) for the purpose of granting CPD credit.
- There is no printed certificates available for HCPs practicing inside Saudi Arabia.
- For HCPs participants from outside Saudi Arabia, please contact [email protected]
- We encourage you to complete the Activity Evaluation to provide feedback for future CPD Activities.
DISCLAIMER
- While the publisher (CREDIT HOURS CO.) and Editorial Board make every effort to ensure that the information, material, drug doses and other quantities contained within this activity are as accurate, complete, and up to date as possible, you should exercise your own independent skill and judgement before you rely on it. as well, you are advised that drug usage described within this activity should only be followed in conjunction with the drug manufacturer's own published literature.
- This activity is not a substitute for independent professional advice and users should obtain any appropriate professional advice relevant to their particular circumstances.
- If you have any changes, additions, or comments, please feel free to contact us through [email protected], we will make appropriate corrections and additions that are brought to our attention.
- We do not recommend the off label use of medicines.
- Not all products/drug classes listed may be locally approved for mentioned indications.
- Please refer to your local prescribing information for approved indications and recommended dosing information.
CONTRIBUTORS & EDITORIAL BOARD
CONTRIBUTORS & SPEAKERS Names & Biographies
CONTRIBUTOR DISCLOSURES
CREDIT HOURS policies and editorial process are designed to ensure that our content remains impartial and unbiased. To accomplish this, we collect information on relevant financial relationships within the previous two years with commercial interests from contributors.
All contributors have disclosed no relevant financial relationships.
All contributors have disclosed no relevant financial relationships.
COMMERCIAL SUPPORT
- This module is supported by an independent educational grant from: Sponsor
- Aggregate participant data will be shared with commercial supporters of this module as per Saudi Food and Drug Authority (sFDA) official Guidance on Disclosure and Transparency, Commercial Supporter will share details, and any financial support that will be provided to all healthcare professionals (HCPs) participating this module, commercial supporter will also disclose certain identifying information of HCPs including without limitation, full names, National Provider Identifier, licensure number(s), specialty, and email address to comply with sFDA Guidance and other legal and ethical requirements.
COURSE STRUCTURE
This activity contains topic, entitled:
- An early and under-recognized disease By Speaker 01 (15 minutes)
- Advances in Imaging and Heart Failure By Speaker 02 (15 minutes)
- HF: Fatal and Forgotten CV complication of Diabetes By Speaker 03 (15 minutes)
- DAPA-HF: Dapagliflozin offers new approach to treatment of HFrEF, even without diabetes By Speaker 04 (10 minutes)
- Post-test (5 minutes)
exame
POSTTEST
At the end of this activity you will receive Posttest questions, The Posttest measure the amount of learning you have acquired upon completion of the this activity. Upon completion of the Posttest with a score at or above 80%, you will get 1 CPD hour accredited by..
At the end of this activity you will receive Posttest questions, The Posttest measure the amount of learning you have acquired upon completion of the this activity. Upon completion of the Posttest with a score at or above 80%, you will get 1 CPD hour accredited by..
CONTACT US
For questions regarding the content of this module and CPD credits, contact [email protected]
For technical assistance, contact [email protected]
For technical assistance, contact [email protected]
REQUEST FOR PARTICIPATION
PARTICIPATION- FREE
Slots left - 0 | Registration closed, we are still accepting applications for our waiting list
- We will do the registration for you once a seat becomes available!
- There are no fees for participating in or receiving credit for this Activity.
- Click request for participation,
- Entering your information,
- Review and Submit the request,
- Receive registration email include Login Details,
- Save the Login Details and use it whenever you have time to study.
If you have multiple accounts, we will have to merge all of your accounts into one.
To know how to use the e-learning system, please read user guide
Please email us your information at [email protected] and our registrars will be happy to assist you.
If you accept TERMS & CONDITIONS and PRIVACY POLICY please click "REGISTER NOW" button
CANCELLATION POLICY
If you are unable to participate in this activity, please email us via [email protected] to give a chance for substituting delegates attending in your place
